APA (7th ed.) Citation

Tabouret, E., Furtner, J., Graillon, T., Silvani, A., Le Rhun, E., Soffietti, R., . . . Preusser, M. (2024). 3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas. Neuro-Oncology, 26(7), . https://doi.org/10.1093/neuonc/noae037

Chicago Style (17th ed.) Citation

Tabouret, Emeline, et al. "3D Volume Growth Rate Evaluation in the EORTC-BTG-1320 Clinical Trial for Recurrent WHO Grade 2 and 3 Meningiomas." Neuro-Oncology 26, no. 7 (2024). https://doi.org/10.1093/neuonc/noae037.

MLA (9th ed.) Citation

Tabouret, Emeline, et al. "3D Volume Growth Rate Evaluation in the EORTC-BTG-1320 Clinical Trial for Recurrent WHO Grade 2 and 3 Meningiomas." Neuro-Oncology, vol. 26, no. 7, 2024, https://doi.org/10.1093/neuonc/noae037.